715 SP 15 (Univasc 15 mg)
Generic Name: moexipril
Pill imprint 715 SP 15 has been identified as Univasc 15 mg.
Univasc is used in the treatment of diabetic kidney disease; left ventricular dysfunction; high blood pressure; heart failure; heart attack and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Univasc 15 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- moexipril
- Imprint:
- 715 SP 15
- Strength:
- 15 mg
- Color:
- Pink
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Schwarz Pharma
- National Drug Code (NDC):
- 00091-3715
- Inactive Ingredients:
- lactose
magnesium oxide
crospovidone
magnesium stearate
gelatin
hydroxypropyl cellulose (type h)
hypromelloses
polyethylene glycol 6000
titanium dioxide
ferric oxide red
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-4276 | A-S Medication Solutions, LLC (repackager) |
Note: Inactive ingredients may vary.
More about Univasc (moexipril)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
